Kurdish Doctor Returns from Sweden to Treat Parkinson’s Patients in Kurdistan
Renowned Kurdish neurologist Dr. Bzhar Najjar returns from Sweden to revolutionize Parkinson's care in Kurdistan. Introduces advanced Apomorphine Pump treatment, aims to make Region a hub for movement disorder therapy.
ERBIL (Kurdistan24) – After years of service in Sweden, renowned Kurdish neurologist Dr. Bzhar Najjar has returned to the Kurdistan Region with a mission to provide advanced medical care to patients suffering from Parkinson’s disease.
Dr. Najjar, who serves as the Chief Physician of the Movement Disorders Department at Miller Hospital in Eskilstuna, Sweden, spoke to Kurdistan24 about his decision to bring his expertise back to his homeland.
“Parkinson’s disease can be managed effectively with medication during the first six years of its onset,” Dr. Najjar explained. “However, if not treated during this period, symptoms such as tremors and muscle stiffness intensify, and the patient’s mobility becomes significantly limited.”
Addressing advanced stages of the disease, Dr. Najjar said, “When symptoms worsen, patients require procedural interventions. There are three types of such procedures, one of which is the Apomorphine Pump, implanted under the skin. This device helps the patient move more freely and reduces tremors.”
Dr. Najjar emphasized that one of his key goals is to make this form of treatment more accessible within Kurdistan. “We are working to ensure that patients in Kurdistan can receive effective Parkinson’s treatment without needing to travel abroad. In fact, we aim to attract patients from other countries to come here for care,” he noted.
The Apomorphine Pump, currently imported from France, is already being used for patients in the Kurdistan Region. “Our aim is to provide this treatment free of charge to those in need within the Region,” he stated, underlining a strong commitment to building a sustainable and inclusive neurological care system in Kurdistan.
